Pharmacokinetics and Safety of Single Oral Doses of Emtricitabine in Human Immunodeficiency Virus-Infected Children

Emtricitabine (FTC; Emtriva), a potent deoxycytidine nucleoside reverse transcriptase inhibitor, has recently been approved by the U.S. Food and Drug Administration for the treatment of human immunodeficiency virus (HIV) infection. In adults, FTC has demonstrated linear kinetics over a wide dose ran...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wang, Laurene H., Wiznia, Andrew A., Rathore, Mobeen H., Chittick, Gregory E., Bakshi, Saroj S., Emmanuel, Patricia J., Flynn, Patricia M.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2004
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC310155/
https://ncbi.nlm.nih.gov/pubmed/14693538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.1.183-191.2004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires